Fluconazole, a New Antifungal Agent
Authors: John N. Galgiani
Journal: Annals of Internal Medicine (1990)

Editorials1 August 1990Fluconazole, a New Antifungal AgentJohn N. Galgiani, MDJohn N. Galgiani, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-113-3-177 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn January, fluconazole was licensed by the Food and Drug Administration (FDA) for use in treating cryptococcosis and candidal infections in the United States. Interest in this compound among investigators has been much broader because fluconazole has shown activity in experimental animal infections that include coccidioidomycosis, histoplasmosis, blastomycosis, and aspergillosis. This azole congener is the most recent of several to be licensed for the treatment of systemic fungal infections. The first, miconazole, has not been widely used. This agent typically requires several daily parenteral doses and produces its own set of toxicities. Ketoconazole was the next azole antifungal to be...References1. SugarAlsipGalgiani ASJ. Pharmacology and toxicity of high-dose ketoconazole. Antimicrob Agents Chemother. 1987; 31:1874-8. CrossrefMedlineGoogle Scholar2. Dismukes W. Azole antifungal drugs: old and new. Ann Intern Med. 1988;109:177-9. LinkGoogle Scholar3. Washton H. Review of fluconazole: a new triazole antifungal agent. Diagn Microbiol Infect Dis. 1989;12:229S-33S. CrossrefMedlineGoogle Scholar4. BrammerFarrowFaulkner KPJ. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990; 12:S318-26. CrossrefMedlineGoogle Scholar5. PerfectDurack JD. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother. 1985;16: 81-6. CrossrefMedlineGoogle Scholar6. ArndtWalshMcCullyBalisPizzoPoplack CTCFPD. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis. 1988;157:178-80. CrossrefMedlineGoogle Scholar7. TuckerWilliamsArathoon RPE. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother. 1988;32:369-73. CrossrefMedlineGoogle Scholar8. LazarWilner JK. Drug interactions with fluconazole. Rev Infect Dis. 1990;12:S327-33. CrossrefMedlineGoogle Scholar9. MitchellHolland AJ. Fluconazole and phenytoin: a predictable interaction. BMJ. 1989;298:1315. CrossrefMedlineGoogle Scholar10. DupontDrouhet BE. Cryptococcal meningitis and fluconazole [Letter]. Ann Intern Med. 1987;106:778. LinkGoogle Scholar11. JonesMarriotSpeed PDB. Efficacy of fluconazole in cryptococcal meningitis. Diagn Microbiol Infect Dis. 1989;12:235S-8S. CrossrefMedlineGoogle Scholar12. SugarSaunders AC. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med. 1988;85:481-9. CrossrefMedlineGoogle Scholar13. SternHartmanSharkey JBP. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med. 1988;85:477-80. CrossrefMedlineGoogle Scholar14. EspositoFoppaAntinori RCS. Fluconazole for cryptococcal meningitis [Letter]. Ann Intern Med. 1989;110:170. LinkGoogle Scholar15. TozziBordiGalgani VES. Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med. 1989;87:353. CrossrefMedlineGoogle Scholar16. ShuttleworthPhilpotKnight DCA. Cutaneous cryptococcosis: treatment with oral fluconazole. Br J Dermatol. 1989;120:683-7. CrossrefMedlineGoogle Scholar17. DismukesCloudThompson WGS. Fluconazole (FLU) versus amphotericin B (AMB) therapy (Rx) of acute cryptococcal meningitis (CM). Program and Abstracts of the Twenty-Ninth InterScience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1989:282A. Google Scholar18. LarsenLealChan RML. Fluconazole compared to amphotericin B plus flucytosine for the treatment of cryptococcal meningitis: a prospective study. Ann Intern Med. 1990;113:183-187. LinkGoogle Scholar19. Dismukes W. Cryptococcal meningitis in patients with AIDS. J Infect Dis. 1988;157:624-8. CrossrefMedlineGoogle Scholar20. DeWitWeertsGoossensClumeck SDHN. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet. 1989;1:746-8. CrossrefMedlineGoogle Scholar21. HayClayton RY. Fluconazole in the management of patients with chronic mucocutaneous candidosis [Letter]. Br J Dermatol. 1988;119:683-4. CrossrefMedlineGoogle Scholar22. HendelSvejgaardWalsoeKiefferStenderup LEIMA. Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole. Scand J Gastroenterol. 1988;23:1182-6. CrossrefMedlineGoogle Scholar23. LevineBernardIdelsonFarnhamSaundersSugar JDBHCA. Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. Am J Med. 1989;86:825-7. CrossrefMedlineGoogle Scholar24. IsalskaStanbridge BT. Fluconazole in the treatment of candidal prosthetic valve endocarditis. BMJ. 1988;297:178-9. CrossrefMedlineGoogle Scholar25. DupontDrouhet BE. Fluconazole for the treatment of fungal diseases in immunosuppressed patients. Am N Y Acad Sci. 1988; 544:564-70. CrossrefMedlineGoogle Scholar26. CatanzaroFiererFriedman AJP. Fluconazole in the treatment of persistent coccidioidomycosis. Chest. 1990;97:666-9. CrossrefMedlineGoogle Scholar27. LabadieHamilton ER. Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B. Arch Intern Med. 1986;146:2013-8. CrossrefMedlineGoogle Scholar28. TuckerGalgianiDenning RJD. Treatment of coccidioidal meningitis with fluconazole. Rev Infect Dis. 1990;12:S380-9. CrossrefMedlineGoogle Scholar29. TuckerDenningDupontStevens RDBD. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med. 1990; 112:108-12. LinkGoogle Scholar30. PattersonMiniterAndriole TPV. Efficacy of fluconazole in experimental invasive aspergillosis. Rev Infect Dis. 1990;12:S281-5. CrossrefMedlineGoogle Scholar31. DismukesCloudGallis WGH. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987;317:334-41. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Veterans Affairs Medical Center College of Medicine University of Arizona Tucson, AZ 85723 Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByEmerging Prospects for Combating Fungal Infections by Targeting Phosphatidylinositol Transfer ProteinsFluconazolium oxalate: synthesis and structural characterization of a highly soluble crystalline formBiodistribution of free and encapsulated 99mTc-fluconazole in an infection model induced by Candida albicansA yolk shell Fe3O4 @[email protected]/Chitosan nanocomposite -modified carbon ionic liquid electrode as a new sensor for the sensitive determination of fluconazole in pharmaceutical preparations and biological fluidsCritical Considerations in Anticancer Drug Development and Dosing Strategies: The Past, Present, and FutureProphylactic Measures During Induction for Acute Myeloid LeukemiaDesign, synthesis, and evaluation of (2 S ,4 R )-Ketoconazole sulfonamide analogs as potential treatments for Metabolic SyndromeAspergillosis and its resistance: Marine natural products as future treatmentSuccessful Treatment by Voriconazole of Aspergillus niger Peritonitis in Automated Peritoneal Dialysis PatientAspergillus Niger Peritonitis in APD, Patient: a Case ReportThe Use of Antifungal Therapy in Neonatal Intensive CareTreatment of asymptomatic pulmonary cryptococcosis in immunocompetent hosts with oral fluconazoleMedical Complications of MothersDrugs in Breast Milk and Effects on InfantsAzoles and antidepressants: a mini-review of the tolerability of co-administrationTherapeutic armamentarium against systemic fungal infectionsFungal Peritonitis in Peritoneal Dialysis PatientsMedical complications of the motherVitrectomy with Fluconazole Infusion: Retinal Toxicity, Pharmacokinetics, and Efficacy in the Treatment of Experimental Candidal EndophthalmitisSystemic mycoses in the immunocompromised host: an update in antifungal therapyComparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitisEffect of Prolonged Fluconazole Treatment on Candida albicans in Diffusion Chambers Implanted into MiceCryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole TherapyTherapy of cryptococcal meningitis in non-HIV-infected patientsNosocomial Infections in the ICUOriginal ArticlesPotential Fluconazole-Induced Carbamazepine ToxicityEvaluation of the Fungitest Kit by Using Strains from Human Immunodeficiency Virus-Infected Patients: Study of Azole Drug SusceptibilityA randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropeniaLong-Term Treatment of a Breastfeeding Mother with Fluconazole Resolved Nipple Pain Caused by Yeast: A Case StudyEfficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole mono therapy in acute and chronic AIDS-associated cryptococcosisBiodegradable scleral implant for intravitreal controlled release of fluconazoleNeurological Complications of HIV Infection and AIDSEmergence of Nonalbicans Candida Species in Immunocompromised Leukemia Patients during Fluconazole TreatmentThe costs and consequences of neglected medically necessary oral careSterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passageMonoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacyCandida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazoleThrombocytopenia caused by fluconazole therapyFluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosisPrimary prevention of cryptococcal meningitis by fluconazole in HIV-infected patientsPilzinfektionenEffectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formationItraconazole for the Treatment of Cryptococcosis in CatsA case report and review of mycetoma of the hand: A diagnostic and therapeutic challengeCandida and Oral Candidosis: A ReviewFrom Candida to Torulopsis: Funguria in long-term stay patients under the pressure of fluconazole usePOSTOPERATIVE CANDIDA KERATITIS TREATED SUCCESSFULLY WITH FLUCONAZOLEFamotidinSYSTEMIC DRUGS IN THE TREATMENT OF DERMATOPHYTOSESThe Use of Fluconazole in the Management of Candida Peritonitis in Patients on Peritoneal DialysisSuccessful Use of Fluconazole for Treatment of Urinary Tract Fungal InfectionsFluconazole and Ketoconazole in the Treatment of Oral and Esophageal Candidiasis in AIDS PatientsSynergistic interaction of miconazole and fluconazole at sub-MIC level on Candida albicansFluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS A Randomized TrialLoren Laine, MD, Robin H. Dretler, MD, Chris N. Conteas, MD, Carmelita Tuazon, MD, Frederick M. Koster, MD, Fred Sattler, MD, Kathleen Squires, MD, Muhammed Z. Islam, PhDProphylaxis and treatment of fungal infections with fluconazole in bone marrow transplant patientsStandardized susceptibility testing of fluconazole: an international collaborative studyPersistence of the same Candida albicans strain despite fluconazole therapyCryptococcal Infection in AIDSEsophageal disease in the acquired immunodeficiency syndrome: Etiology, diagnosis, and managementEVALUATION AND TREATMENT OF LATER MANIFESTATIONS OF HIV INFECTIONRapid and sensitive assay for fluconazole which uses gas chromatography with electron capture detectionEffects of fluconazole on the sterol and carbohydrate composition of four species ofCandidaAntifungal Agents Used for Deep-Seated Mycotic InfectionsSynergistic postantifungal effect of flucytosine and fluconazole on Candida albicansFluconazole in the treatment of onychomycosis caused by dermatophytesIncrease in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleIn vitro comparative evaluations of the postantifungal effect: synergistic interaction between flucytosine and fluconazole against Candida albicansFluconazole: A New Triazole Antifungal AgentAntifungal Therapy in CAPD Peritonitis-Do We Have a Choice?Overview: Cryptococcosis in the patient with AIDSCommunity-Acquired Fungal DiseasesFluconazole, Itraconazole and Ketoconazole In- Vitro Activity. A Comparative StudySafety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.FluconazoleFeedback from the Sixth International AIDS Conference, San Francisco 1990.Fluconazole-Induced ThrombocytopeniaAnupam Agarwal, MD, V. Sakhuja, MD, K.S. Chugh, MDProphylaxe und Therapie von Pilzinfektionen mit Fluconazol bei Patienten nach KnochenmarktransplantationCryptococcose bei AIDS: Therapeutische Konzepte 1 August 1990Volume 113, Issue 3Page: 177-179KeywordsAntifungalsAspergillosisBlastomycosisCoccidioidomycosisCryptococcosisFood and Drug AdministrationHistoplasmosisMycosesToxicity Issue Published: 1 August 1990 PDF DownloadLoading ...